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Consequences of Two Different Amino-Acid
Substitutions at the Same Codon in KRT14
Indicate Definitive Roles of Structural Distortion
in Epidermolysis Bullosa Simplex Pathogenesis
Ken Natsuga1, Wataru Nishie1, Brian J. Smith2,3, Satoru Shinkuma1, Thomasin A. Smith4, David A.D. Parry4,5,
Naoki Oiso6, Akira Kawada6, Kozo Yoneda7, Masashi Akiyama1,8 and Hiroshi Shimizu1
Numerous inherited diseases develop due to missense mutations, leading to an amino-acid substitution.
Whether an amino-acid change is pathogenic depends on the level of deleterious effects caused by the amino-
acid alteration. We show an example of different structural and phenotypic consequences caused by two
individual amino-acid changes at the same position. Epidermolysis bullosa simplex (EBS) is a genodermatosis
resulting from KRT5 or KRT14 mutations. Mutation analysis of an EBS family revealed that affected individuals
were heterozygous for a, to our knowledge, previously unreported mutation of c.1237G4C (p.Ala413Pro) in
KRT14. Interestingly, 2 of 100 unrelated normal controls were heterozygous, and 1 of the 100 was homozygous
for a different mutation in this position, c.1237G4A (p.Ala413Thr). In silico modeling of the protein demonstrated
deleterious structural effects from proline substitution but not from threonine substitution. In vitro transfection
studies revealed a significantly larger number of keratin-clumped cells in HaCaT cells transfected with mutant
KRT14 complementary DNA (cDNA) harboring p.Ala413Pro than those transfected with wild-type KRT14 cDNA
or mutant KRT14 cDNA harboring p.Ala413Thr. These results show that changes in two distinct amino acids at a
locus are destined to elicit different phenotypes due to the degree of structural distortion resulting from the
amino-acid alterations.
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INTRODUCTION
Keratins are the largest group of intermediate filament
proteins, which are expressed in epithelial cells (Schweizer
et al., 2006). The prominent intermediate filaments consist
of keratins K1–K20, which are further classified into types I
(K9–K20) and II (K1–K8). Type I and II keratins form non-
covalent type I/II keratin heteropolymers (Moll et al., 1982).
Unique keratin expression serves as specific markers that
characterize different epithelial cell types. Of the many kinds
of epithelial cells that exist, basal epidermal keratinocytes
preferentially express K5/K14 heteropolymers (Moll et al.,
1982; Nelson and Sun, 1983). These, in turn, form predomi-
nantly heterodimers in vivo (Coulombe and Fuchs, 1990;
Hatzfeld and Weber, 1990; Steinert, 1990), with chains parallel
to one another and in axial register (Conway and Parry, 1990;
Steinert et al., 1993).
Epidermolysis bullosa (EB) comprises a group of hetero-
geneous disorders in which congenital skin fragility leads to
dermal–epidermal junction separation. EB has been subdi-
vided into three major groups (EB simplex, junctional EB, and
dystrophic EB) and one minor subtype (Kindler syndrome)
based on the level of blister formation (Fine et al., 2008). So
far, mutations in 14 different genes have been identified as
underlying EB subtypes (Fine et al., 2008; Groves et al.,
2010). Among them, mutations in either the KRT5 or KRT14
gene, which encodes K5 and K14, respectively, lead to EB
simplex (EBS) (Coulombe et al., 1991; Lane et al., 1992;
Yasukawa et al., 2006). According to the clinical severity of
blister formation, EBS can be further subdivided into three
major subtypes (Fine et al., 2008). The mildest variant is
‘‘EBS, localized’’ (EBS-loc), with blistering confined to the
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hands and feet; the more moderate variant is ‘‘EBS, other
generalized’’ (EBS-gen-non-DM), with generalized blister
formation; and the most severe variant is Dowling–Meara
type (EBS-DM), which is characterized by severe herpetiform
blistering (Fine et al., 2008; Coulombe et al., 2009).
In this study, we identified a, to our knowledge, previously
unreported missense mutation in KRT14 from a family with
EBS-loc. We also detected a different nucleotide substitution
at the same position in KRT14 in normal control individuals.
To clarify whether each nucleotide substitution is pathogenic,
we used molecular modeling to predict the effect on the
structure that results from a single amino-acid change, and
we examined cultured cells transfected either with wild-type
or with mutated KRT14 complementary DNA (cDNA). Here,
we show that two kinds of amino-acid changes at the same
position of KRT14 lead to totally different cell function
in vitro and phenotypes in vivo.
RESULTS
Case description
The proband was a 10-year-old male with blistering on his
soles (Figure 1a). Blisters on his hands and feet were observed
during infancy. New blisters tended to emerge more in the
summer. Nail deformity was also noted (Figure 1b). Ultra-
structural features of skin specimens from the proband
revealed many vacuoles scattered between the nucleus and
basal lamina in the basal keratinocytes (Figure 1c). His family
had several affected members (Figure 1d).
Detection of a novel KRT14 mutation in a family with EBS and
another nucleotide substitution at the same position of KRT14
in normal controls
Direct sequencing of the KRT5/KRT14 gene revealed that the
proband (III-2, Figure 1d) was heterozygous for the, to our
knowledge, previously unreported mutation of c.1237G4C
transversion (p.Ala413Pro) in the helix termination motif of
KRT14 (Figure 2a). No other mutations were detected in any
of the exons or exon–intron boundaries of KRT5 and KRT14.
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Figure 1. Clinical and ultrastructural features of a family with epidermolysis
bullosa simplex. (a) Blisters and erosions are seen in the proband’s right sole
(arrows). (b) Toenail deformities are observed in the proband. (c) Ultrastructural
features of the proband’s lesional skin sample show basal cell cytolysis
(bar¼ 5mm). No apparent keratin clumps are seen. (d) Pedigree of the
proband’s family. Affected individuals are indicated by black fill. The proband
is indicated by an arrow.
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Figure 2. KRT14 mutation analysis. (a) The proband (III-2) is heterozygous
for c.1237G4C (p.Ala413Pro) in KRT14 (an arrow). (b) In all, 2 out of 100
normal controls are heterozygous for c.1237G4A (p.Ala413Thr; an arrow).
(c) Similarly, 1 out of 100 normal controls is homozygous for c.1237G4A
(p.Ala413Thr; an arrow). (d) The proband’s uncle (II-3) is compound
heterozygous for c.1237G4C (p.Ala413Pro) and c.1237G4A (p.Ala413Thr;
an arrow). (e) The wild-type sequence. (f) Mutant allele–specific amplification
shows that affected family members (Figure 1d) harbor c.1237G4C
(p.Ala413Pro).
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Affected family members were also heterozygous for the
same mutation in KRT14 (I-1, II-1, II-3, III-1, and III-5; Figure
1d), and unaffected family members did not have that
mutation (I-2, II-2, and III-3; Figure 1d). Mutant allele-specific
amplification analysis demonstrated that a 300-bp fragment
derived from the mutant allele was amplified from the
genomic DNA of affected family members (Figures 1d and
2f). This mutation was not found in 200 normal unrelated
alleles (100 Japanese individuals) by direct sequencing.
Unexpectedly, 2 of the 100 normal Japanese controls were
heterozygous for c.1237G4A transition (p.Ala413Thr) in
KRT14 (Figure 2b), and 1 of the 100 normal controls was
homozygous for the same nucleotide transition (Figure 2c).
These three individuals with the c.1237G4A transition
(p.Ala413Thr) in KRT14 had no history of skin fragility or
nail dystrophy. Interestingly, the proband’s unaffected grand-
mother (I-2) and affected uncle (II-3) were also heterozygous
for the c.1237G4A transition (p.Ala413Thr) in KRT14. The
proband’s affected uncle (II-3) was compound heterozygous
for p.Ala413Thr and p.Ala413Pro (Figure 2d). However, his
clinical manifestations were similar to those of the other
affected family members. The proband’s unaffected cousin
(III-4) is expected to be heterozygous for p.Ala413Thr—
mutation analysis could not be performed without her consent.
Molecular dynamics predicts the deleterious structural change
resulting from p.Ala413Pro substitution in keratin 14 but not
from p.Ala413Thr
An initial structure of the native K5/K14 heterodimer and
the p.Ala413Thr and p.Ala413Pro mutants, representing the
C-terminal 35 residues of each chain, was generated by
comparative modeling. The first 29 residues of each chain
form a classical coiled coil in which generally hydrophobic
residues occupy the heptad-repeat positions ‘‘a’’ and ‘‘d’’
(Figure 3a), a lysine at position 405 in K14 and 460 in K5,
conserved among human intermediate filament proteins
(Strelkov et al., 2002), interact with each other through the
hydrophobic portion of their side chains.
The structure of the native K5/K14 and the two mutants
were subjected to molecular dynamics (MD) simulations to
explore the structural stability. The secondary structure
content in each of the chains throughout the MD simulations
is presented in Figure 3b–d—in this figure, a-helix conforma-
tion is represented in blue. In this native heterodimer (Figure
3b), the a-helix content remains essentially unchanged
throughout the simulation—both peptides maintain helical
geometry across the coiled-coil domains (residues 449–474 in
K5 and 394-419 in K14). At the C termini of K5 and K14, a
stable bend (green), flanked on the N-terminal side by a
stable short turn (yellow), is observed. In K5, a short 310 helix
(gray) forms after B16 nanoseconds and is stable for the
remainder of the simulation. Thus, the structure, and
particularly the secondary structure conformation, remains
constant throughout the simulation in the native complex.
The p.Ala413Thr mutation introduces a slight instability
in the helix at the site of the mutation (black triangle),
represented by an infrequent change in conformation to
‘‘turn’’ during the simulation (shown in yellow; Figure 3c).
However, the overall a-helix content in this mutant is very
similar to that observed for the native (Figure 3b). In contrast,
in the p.Ala413Pro, peptide predominantly adopts a non-
helical conformation at the position of the mutation through-
out the simulation (Figure 3d). This change in conformation is
also associated with additional instability (turn and coil
conformation) in the helical conformation of residues
C-terminal of the mutation site in both the K5 and K14 peptides
(Figure 3d). Thus, the p.Ala413Thr mutation introduces a
slight instability into the structure of the complex, whereas
the p.Ala413Pro mutation causes significant disruption to the
secondary structure in the C-terminal region of both peptides.
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Figure 3. Molecular dynamics (MD) of the keratin heterodimer. (a) Sequences of the keratin helix motif and the heptad-repeat positions in K5 and K14.
(b–d) MD simulations. The changes in secondary structure due to an amino-acid substitution were visualized through the MD. These simulations were each run
for 50.0 nanoseconds. Blue indicates the a-helix. The native (b) and p.Ala413Thr (c) peptides retain a-helix geometry (blue colored) throughout the simulation.
In contrast, increased instability in the a-helix was observed in the p.Ala413Pro-mutant peptide (d) bound with K5, which is indicated by the appearance of
yellow-colored turn motif (arrowheads). In the p.Ala413Pro peptide (d), the helical geometry at the C terminus of both K14 and K5 is substantially compromised
throughout the simulation—K5 is unstructured (coil geometry), and K14 alternates between coil, bends, and turns geometries. (e) A schematic diagram
of K14 structure. Note that Ala413 is located at the helix termination motif (HTM) of the keratin molecule. Ala413 corresponds to position ‘‘b’’ of the heptad
repeat (abcdefg) and is conserved among keratin polypeptides. (f) K14 amino-acid sequence alignment shows the level of conservation in diverse species
of the amino acid Ala413 (red characters).
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An alanine to proline substitution at the 413 locus of KRT14
protein disrupts the KIF network in HaCaT cells, whereas
alanine to threonine does not
We examined whether the clinical heterogeneity between
individuals with wild-type, p.Ala413Thr, and p.Ala413Pro
mutations in KRT14 could be demonstrated in a cell culture
system. Three mammalian expression vectors containing the
wild-type KRT14 cDNA (K14WT), the mutated KRT14
cDNA correspondent with the p.Ala413Thr substitution
(K14A413T), and the p.Ala413Pro substitution (K14A413P)
were transiently transfected into HaCaT cells. Detection of
K14 was performed by probing the V5 epitope tag.
Immunoblot analysis confirmed that each construct was
successfully transferred into the HaCaT cells (Figure 4a).
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Figure 4. In vitro assay using HaCaT cells transfected with mutated KRT14 complementary DNA (cDNA). (a) Immunoblot analysis reveals that HaCaT cells
transfected with either wild-type (K14WT) or mutated KRT14 cDNA (K14A413T and K14A413P) express V5-tagged K14 molecules. Equal protein loading was
confirmed by reprobing with AC15 (anti-b-actin antibody). HaCaT cells transfected with K14WT (b), K14A413T (c), or K14A413P (d; bar¼5 mm). To visualize
the transfected gene product, cells were stained with FITC-conjugated anti-V5 antibody. Cells transfected with K14WT and K14A413T have a normal
keratin filament network (b, c), whereas significantly more cells transfected with K14A413P exhibit small ball-like clump formation (d). (e) The percentage
of cells showing keratin aggregate formation among transfected cells is compared. There are significantly more clumps observed in the K14A413P-transfected
cells (49±8%) than in those transfected with either K14WT (17±3%) or K14A413T (6±4%). Each value shown represents the mean±SEM of 10 individual
samples. The statistical significance of the differences between groups is assessed by one-way analysis of variance, followed by Tukey’s test (*Po0.05).
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Transfection efficiency was up to 50% as judged from the
immunofluorescence of the V5 epitope tag in transfected
cells. The cells transfected with either K14WT or K14A413T
showed fine bundles of keratin filaments extending through-
out the cytoplasm without disturbing the cells’ morphology
(Figure 4b and c), whereas cells transfected with K14A413P
exhibited small ball-like filament aggregates, indicating a
disruption in the keratin network (Figure 4d). The percentage
of the transfected cells harboring keratin clumping in each
transfection assay was as follows: K14WT (mean, 17%),
K14A413T (6%), and K14A413P (49%; Figure 4e). Statistical
analysis showed that significantly more clumped cells were
observed in HaCaT cells transfected with K14A413P than
in those transfected with K14WT or K14A413T (Po0.05;
Figure 4e).
Although not statistically significant (P40.05), fewer
keratin-clumped cells were observed in HaCaT cells trans-
fected with K14A413T than those transfected with K14WT
(Figure 4e). To clarify whether p.Ala413Thr mutation has a
protective effect on keratin aggregation, three different
transfections using HaCaT cells were performed, including
K14A413P alone, a combination of equal amounts of
K14A413P and K14A413T (K14A413P/K14A413T), and a
combination of equal amounts of K14A413P and K14WT
(K14A413P/K14WT). The percentage of the transfected
cells harboring keratin clumping in each transfection
assay was as follows: K14A413P (mean, 42%), K14A413P/
K14A413T (32%), and K14A413P/K14WT (30%; Supplemen-
tary Figure S1 online). The differences in the percentage
of keratin-clumped cells between K14A413P/K14A413T
and K14A413P/K14WT were not statistically significant
(P40.05), indicating that the p.Ala413Thr mutation is
unlikely to have a protective effect on keratin aggregation
compared with the wild-type sequence.
We further performed three different transfections
(K14WT, K14A413T, and K14A413P) into HeLa cells, in
which endogenous K5 and K14 were not expressed but K8
was present as a potential partner of recombinant K14
(Hatzfeld and Franke, 1985; Albers and Fuchs, 1987).
The percentage of the transfected cells harboring keratin
aggregation in each transfection assay was as follows:
K14WT (mean, 14%), K14A413T (10%), and K14A413P
(77%; Supplementary Figure S2 online). Statistical analysis
showed that significantly more clumped cells were observed
in HeLa cells transfected with K14A413P than in those
transfected with K14WT or K14A413T (Po0.05; Supplemen-
tary Figure S2 online), confirming the deleterious effect of
p.Ala413Pro mutation in K14 on keratin filament network.
In contrast, no keratin clumping was observed in normal
human epidermal keratinocytes (NHEKs) transfected with any
of the three plasmids (K14WT, K14A413T, and K14A413P;
Supplementary Figure S3 online).
DISCUSSION
A single-nucleotide change in the protein-coding region that
leads to an amino-acid substitution can be assigned either as
a non-synonymous-coding single-nucleotide polymorphism
or as a missense mutation. Numerous single-gene diseases
have been attributed to missense mutations. However, it is
sometimes difficult to demonstrate the effects of an amino-
acid substitution on protein function and disease phenotype
(Thusberg and Vihinen, 2009); it has been recently shown
that the p.Met119Thr and p.Met119Val mutations in K14
result in EBS-DM and EBS-gen-non-DM, respectively (Cum-
mins et al., 2001). Our study provides a good model to study
the pathogenicity of a single amino-acid substitution, as
replacement of Ala413 in K14 with proline results in an
EBS family, whereas replacement with threonine results in
normal controls.
Ala413 is located in the helix termination motif of K14 and
corresponds to position ‘‘b’’ of the heptad repeat (abcdefg)
that is conserved among keratin polypeptides (Figure 3e),
where ‘‘a’’ and ‘‘d ’’ are usually non-polar amino acids and
the others are polar or charged. Ala413 is highly conserved
among species (Figure 3f).
Proline lacks an amide hydrogen atom and is unable to
form a hydrogen bond with the carbonyl oxygen atom of the
four amide residues N-terminal of it in an a-helix; thus,
proline residues act as a-helix disruptors (although the
stability of a-helices harboring a proline may be environment
specific (Li et al., 1996)). Previous reports using crystal X-ray
analysis showed marked structural perturbations by proline
residues in polypeptides (MacArthur and Thornton, 1991).
Keratin has a conserved structure with helix motifs, and
proline substitutions in these motifs have been reported to
cause marked structural perturbations (Letai et al., 1992).
As for EBS, proline substitutions in K5/K14 have been
described in 34 cases in the Human Intermediate Filament
Database (http://www.interfil.org/; Szeverenyi et al., 2008),
although no non-synonymous-coding single-nucleotide poly-
morphisms have been detected in the database that cause
proline substitutions. Clinical manifestations in EBS with
proline substitutions vary between the localized and
Dowling–Meara types, although proline substitutions in
helix motifs tend to lead to EBS-DM, and those substit-
utions in domains outside helix motifs are more often
observed in EBS-gen-non-DM.
A Taiwanese patient with EBS-loc has been described as
heterozygous for p.Ala413Thr in K14 (Chao et al., 2002).
However, p.Ala413Thr was recently found in 6 of 112 alleles
in normal Japanese individuals (Hattori et al., 2006). Our
study confirmed the presence of normal control indivi-
duals who are heterozygous for p.Ala413Thr (Figure 2b).
Furthermore, a single normal control was homozygous for
p.Ala413Thr (Figure 2c), which lowers the possibility of
pathogenic effects from threonine substitution at this amino
acid. Threonine and alanine substitute for one another on a
frequency commensurate with their occurrence in structured
proteins (Henikoff and Henikoff, 1992). Thus, structurally
they can be considered interchangeable. Proline, on the
other hand, is seldom observed to substitute for any residue,
including alanine, highlighting its unique structural charac-
teristics. Our in vitro study using HaCaT cells confirmed
that it is not threonine substitution but proline substitu-
tion that causes keratin aggregation. Nevertheless, it is
possible that p.Ala413Thr is a phenotypical mutation in
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certain environmental conditions, as many contributing
factors including temperature, trauma, and location of blister
formation can affect the development of blistering pheno-
types (Coulombe et al., 2009).
Modeling of K5/K14 mutations in coiled-coil structures
provides evidence that a correlation exists between the
clinical severity of EBS and the degree of structural distortion
caused by the underlying amino-acid change (Smith et al.,
2004). Our study has also demonstrated that MD simulations
of keratin mutations accurately correlate with the pathogeni-
city of an amino-acid substitution.
As HaCaT cells are not normal keratinocytes, their
keratin expression level is different from that of NHEK
(Boukamp et al., 1988). No keratin clumping was seen in
NHEK transfected with any of K14WT, K14A413T, or
K14A413P (Supplementary Figure S3 online). This result
indicates that either overexpressed recombinant K14 is
not enough to disrupt keratin network in NHEK due to a
much higher expression of endogenous K14 in NHEK
than in HaCaT cells (Sorensen et al., 2003). On the other
hand, the balance of keratin network may be substantially
altered when recombinant K14 is overexpressed in HaCaT
cells, in which endogenous K14 is reduced compared with
NHEK (Sorensen et al., 2003). The absence of keratin
aggregation in the proband’s skin keratinocytes (Figure 1c),
compared with what was observed in HaCaT cells
transfected with K14A413P, may reflect the greater effect
of K14 mutant introduction in HaCaT cells compared
with NHEK.
In summary, this study gives insight into consequences
of two different amino-acid substitutions at the same
codon. The biological effects of one amino-acid substitution
are hard to predict. In silico and in vitro analyses are
useful for confirming the pathogenicity of missense
mutations.
MATERIALS AND METHODS
Mutation analysis
Genomic DNA extracted from peripheral blood was used as a
template for PCR amplification. The KRT5 and KRT14 genes were
amplified by methods previously described (Stephens et al., 1997;
Hut et al., 2000). DNA sequencing of the PCR products was carried
out with an ABI 3100 sequencer (PerkinElmer Life Sciences-ABI,
Foster City, CA). The mutation nomenclature follows published
mutation nomenclature guidelines (http://www.hgvs.org/mutnomen)
according to the reference sequence NM_000424.3 for KRT5 and
NM_000526.3 for KRT14, with þ 1 as the A of the ATG initiation
codon.
Mutant allele-specific amplification analysis
To verify the mutation, mutant allele-specific amplification
analysis was performed with mutant allele-specific primers carrying
the substitution of two bases at the 30-end mutant allele-specific
primers (Linard et al., 2002; Sapio et al., 2006): forward, 50-ACGCG
GCTGGAGCAGGAGATTC-30 and reverse, 50-GACAGCACTAGAGC
TCAGCC-30. PCR conditions were as follows: 941C for 5 minutes,
followed by 30 cycles of 941C for 30 seconds, 651C for 30 seconds,
721C for 30 seconds, and extension at 721C for 7 minutes.
Plasmid construction
cDNA containing the entire coding region of KRT14 (K14WT)
subcloned into the pcDNA 3.1/V5-His vector (Invitrogen, Carlsbad,
CA) was employed (Yoneda et al., 2004). The point-mutated KRT14
cDNAs corresponding to the p.Ala413Pro (K14A413P) and
p.Ala1237Thr (K14A413T) mutations were generated with the use
of the GeneTailor Site-Directed Mutagenesis System (Invitrogen).
Sense primers used for the PCR reactions to generate the K14A413P
and the K14A413T fragments were 50-CGCGGCTGGAGCAGGAGA
TCcCCACCTACCGC-30 and 50-CGCGGCTGGAGCAGGAGATCaCCA
CCTACCGC-30, respectively (lower-case letters in bold denote muta-
tions introduced). The anti-sense primer 50-GATCTCCTGCTCCA
GCCGCGTCTTCACGTC-30 was used to generate both of the mutant
KRT14 cDNAs.
Molecular modeling
The structure of segment 2B in human vimentin (PDB 1GK6)
(Herrmann et al., 2000; Strelkov et al., 2002, 2004) was used as a
template in comparative modeling of the K5/K14 hetero-
dimer and the two mutations (K14-A413P and K14-A413T: 2B-
108,b) using the Modeller (9v7) program (Fiser and Sali, 2003). The
nomenclature K14-A413P: 2B-108,b specifies residue 413 in chain
K14, its position 108 within segment 2B, and its position b within the
heptad repeat. From 25 models of each heterodimer, the structure
with the lowest Modeller Objective function was subjected to MD
simulation.
MD simulations using the GROMACS (v4.0) package of programs
(Hess et al., 2008) were performed using the OPLS-aa force field
(Jorgensen and Tirado-Rives, 1988). Ionizable residues were
assumed to be in their charged state, whereas the amine and
carboxyl termini were assumed to be in their neutral form. Each
molecule was solvated in a 75 75 75 A˚3 water box; sodium and
chloride ions were added to neutralize the system and provide a final
ionic strength of 0.154 M. Protein and water (with ions) were coupled
separately to a thermal bath at 300 K using velocity rescaling
(Bussi et al., 2007) applied with a coupling time of 0.1 ps, whereas
the pressure was coupled to an isotropic barostat using a time
constant of 1 ps and compressibility of 4.5 105 bar1. All
simulations were performed with a single non-bonded cutoff of
10 A˚ and applying a neighbour-list update frequency of 10 steps
(20 fs). The particle-mesh Ewald method was used to account for
long-range electrostatics (Essman et al., 1995), applying a grid width
of 1.2 A˚, and a fourth-order spline interpolation. Bond lengths were
constrained using the LINCS algorithm (Hess, 2008; Hess et al.,
2008). All simulations consisted of an initial minimization of water
molecules, followed by 100 ps of MD with the protein restrained.
Following positional restraints of MD, all restraints on the protein
were removed and MD continued for a further 50 ns. Coordinates
were archived throughout the simulation at 100-ps intervals.
Cell culture and plasmid transfection
HaCaT-immortalized keratinocytes and HeLa cells were maintained
in DMEM (GIBCO, Grand Island, NY) supplemented with 10% (v/v)
fetal bovine serum. NHEKs from neonatal foreskin (Lonza, Allendale,
NJ) were cultured in keratinocyte growth medium (Lonza). Three
different transfections (K14WT, K14A413P, and K14A413T) into
HaCaT cells or HeLa cells (2mg of plasmid in six-well dishes) were
performed using Lipofectamine LTX (Invitrogen) according
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to the manufacturer’s instructions. Three different plasmids (K14WT,
K14A413P, and K14A413T) were transfected, respectively, into
NHEK (5mg of plasmid in six-well dishes) with electroporation
using Amaxa Nucleofector apparatus (Amaxa, Cologne, Germany).
Also, three different transfections into HaCaT cells, including
K14A413P alone (2 mg of plasmid in six-well dishes), a combination
of equal amounts of K14A413P (1mg) and K14WT (1mg; K14A413P/
K14WT), and a combination of equal amounts of K14A413P (1mg)
and K14A413T (1mg; K14A413P/K14A413T) were performed using
Lipofectamine LTX (Invitrogen).
Immunoblot analysis
At 24 hours after transfection, HaCaT cells were lysed in Laemmli
buffer (consisting of 62.5 mM Tris-HCl (pH 6.8), 3% SDS, and 5%
mercaptoethanol) on ice for 10 minutes, cell debris was removed by
centrifugation at 14,000 rpm for 5 minutes, and supernatant was
collected. Supernatants were electrophoresed on a NuPAGE 4–12%
bis-Tris gel (Invitrogen) and transferred to a polyvinylidene difluoride
membrane. The membrane was incubated with horseradish perox-
idase-conjugated anti-V5 antibody (Invitrogen) for 1 hour at room
temperature, and the blots were detected using the ECL Plus
Detection Kit (GE Healthcare, Waukesha, WI).
Confocal laser analysis
At 24 hours after transfection, the cells were washed with phosphate-
buffered saline and fixed with methanol. A FITC-conjugated anti-V5
antibody (Invitrogen) was used to detect transfected cells. All cells
were observed using a confocal laser-scanning microscope (Olym-
pus Fluoview FV300, Tokyo, Japan). The cells with keratin
aggregates were counted in five different areas, two from each
experimental replicate (a mean of 42 cells from each replicate), as
described previously (Yasukawa et al., 2002), and the results
obtained from the 10 counts were expressed as the mean±SEM.
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